124
Views
0
CrossRef citations to date
0
Altmetric
Clinical features - Original research

Metabolic comorbidities and systemic arterial hypertension: the challenge faced by HIV patients on long-term use of antiretroviral therapy

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 75-81 | Received 03 Mar 2021, Accepted 07 Jan 2022, Published online: 07 Feb 2022

References

  • Joint United Nations Programme on HIV/AIDS. HIV and aging; [ cited 2020 May 12]. Available from: http://www.unaids.org/en/media/unaids/acontentassets/documents/unaidspublication/2013/20131101_JC2563_hiv-and-aging_en.pdf
  • Weber R, Ruppik M, Rickenbach M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV cohort study: causes of death and HIV infection. HIV Med. 2013;14(4):195–207.
  • Wing EJ. HIV and aging. Int J Infect Dis. 2016;53:61–68.
  • Kara E, Inkaya A, Hakli Aydin D, et al. Polypharmacy and drug- related problems among people living with HIV/AIDS: a single center experience. Turk J Med Sci. 2019;49(1):222–229.
  • Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–818.
  • Serrano-Villar S, Gutiérrez F, Miralles C, et al. Human immunodeficiency virus as a chronic disease: evaluation and management of nonacquired immune deficiency syndrome-defining conditions. Open Forum Infect Dis. 2016;3(2):ofw097.
  • Motumma A, Negesa L, Hunduma G, et al. Prevalence and associated factors of common mental disorders among adult patients attending HIV follow up service in Harar town, Eastern Ethiopia: a cross-sectional study. BMC Psychol. 2019;7(1):11.
  • Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–1126.
  • Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–468.
  • Groot V, Beckerman H, Lankhorst G, et al. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229.
  • Francesco D, Verboeket SO, Underwood J, et al. Patterns of co-occurring comorbidities in people living with HIV. Open Forum Infect Dis. 8(1). [ cited 2020 May 12]. Available from: https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofy272/5144106
  • Executive summary of the consensus document on metabolic disorders and cardivascular risk in patients with HIV infection. Enferm Infecc Microbiol Clin. 2019;37(1):50–55.
  • Pádua CAM, Moura CS. Availability of data on adverse reactions to antiretroviral drugs in medical charts according to the Naranjo Algorithm: an example of a Brazilian Historical Cohort. Clin Drug Investig. 2014;34(6):395–402.
  • Nobre F, Mion Júnior D, Gomes M, et al. 6a Diretrizes de Monitorização Ambulatorial da Pressão Arterial e 4a Diretrizes de Monitorização Residencial da Pressão Arterial. Arq Bras Cardiol. Disponível em. [ cited 2020 May 12]. Available from: http://www.gnresearch.org/doi/10.5935/abc.20180074.
  • Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes. [ cited 2020 May 12]. Available from: https://www.diabetes.org.br/profissionais/images/DIRETRIZES-COMPLETA-2019-2020.pdf
  • World Health Organization. Assessment of fracture risk and its application to screening for Postmenopausal Osteoporosis. WHO Technical Report Series; 1994.
  • Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936–942.
  • Florindo AA, Latorre MDRDDO, Santos ECMD, et al. Validity and reliability of the Baecke questionnaire for the evaluation of habitual physical activity among people living with HIV/AIDS. Cad Saúde Pública. 2006;22(3):535–541.
  • Utami GT, Woferst R, Lubis SL. An overview of physical activities among family members with risk of type 2 diabetes mellitus in Pekanbaru. Enferm Clin. 2019;29:535–541.
  • Centers for Disease Control and Prevention. HIV surveillance report; [cited 2020 May 19]. Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • U.S. Department of Veterans Affairs. CD4 count (or T-cell count). [ cited 2020 May 19]. Available from: https://www.hiv.va.gov/patient/diagnosis/labs-CD4-count.asp
  • Centers for Disease Control and Prevention. Guidance on community viral load: a family of measures, definitions, and method for calculation. 2011.
  • Li X, Ding H, Geng W, et al. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China. BMC Infect Dis. 2019;19(1):373.
  • Dimala CA, Ngu RC, Kadia BM, et al. Markers of adiposity in HIV/AIDS patients: agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index. PLoS ONE. 2018;13(3):e0194653.
  • Kudel I, Alves JS, de Menezes Goncalves T, et al. The association between body mass index and health and economic outcomes in Brazil. Diabetol Metab Syndr. 2018;10(1):20.
  • Bays HE, Chapman RH, Grandy S, the SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys: relation of BMI to diabetes mellitus. Int J Clin Pract. 2007;61(5):737–747.
  • Jaggers JR, Hand GA. Health benefits of exercise for people living with HIV: a review of the literature. Am J Lifestyle Med. 2016;10(3):9.
  • Calza L, Colangeli V, Manfredi R, et al. Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother. 2016;71(6):1451–1465.
  • Da CJ, Maselli LMF, Stern ACB, et al. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: old and new drugs. Wjv. 2015;4(2):56.
  • Husain NE, Noor S, Elmadhoun W, et al. Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten. HIV. 2017;9:193–202.
  • de LBM, C DPCM, Mendicino CCP, et al. Osteopenia and osteoporosis among treatment-experienced people living with HIV. Braz J Infect Dis. 2020. DOI:https://doi.org/10.1016/j.bjid.2020.05.008
  • Serrão R, Piñero C, Velez J, et al. Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: the AGING POSITIVE study. Int J Infect Dis. 2019;79:94–100.
  • SBrazil Health Ministry. Indicadores e Dados Básicos; [ cited 2020 May 16]. cited: http://tabnet.datasus.gov.br/cgi/idb2012/matriz.htm#cober
  • Malta DC, Szwarcwald CL, Machado ÍE, et al. Prevalência de colesterol total e frações alterados na população adulta brasileira: pesquisa Nacional de Saúde. Rev Bras Epidemiol. 2019;22(2):E190005.
  • Marinho BCG, Guerra LP, Drummond JB, et al. The burden of osteoporosis in Brazil. Arq Bras Endocrinol Metab. 2014;58(5):434–443.
  • Nix LM, Tien PC. Metabolic syndrome, diabetes, and cardiovascular risk in HIV. Curr HIV/AIDS Rep. 2014;11(3):271–278.
  • Farhat GN, Newman AB, Sutton-Tyrrell K, et al. The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int. 2007;18(7):999–1008.
  • Chen S-J, Lin C-S, Lin C-L, et al. Osteoporosis is associated with high risk for coronary heart disease: a population-based cohort study. Medicine (Baltimore). 2015;94(27):e1146.
  • Guan X, Xue Y, Wang J, et al. Low bone mineral density is associated with global coronary atherosclerotic plaque burden in stable angina patients. Clin Interv Aging. 2018;13:1475–1483.
  • Jaggers JR, Hand GA. Health benefits of exercise for people living with HIV: a review of the literature. Am J Lifestyle Med. 2016;10(3):9.
  • Sociedade Brasileira de Cardiologia. Atualização das Diretrizes Brasileiras de Dislipidemias; [ cited 2021 May 15]. Available from: http://publicacoes.cardiol.br/2014/diretrizes/2017/02_DIRETRIZ_DE_DISLIPIDEMIAS.pdf
  • Brazil Health Ministry. Nota Técnica No 192/2017 - Cancelamento da Nota Técnica 119/2017 sobre os critérios de priorização temporária para a realização dos testes de quantificação da carga viral do HIV; 2017 [cited 2020 Jul 22]. Available from: http://www.aids.gov.br/pt-br/legislacao/nota-tecnica-n-1922017diahvsvsms
  • Brazil, Minas Gerais State Secretary. Secretaria do Estado de Minas Gerais. Nota Técnica No 02/2017 - Critérios de priorização temporária para a realização dos testes de quantificação viral do HIV. 2018.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.